CG Oncology, Inc. Common stock

CGON

CGONCG Oncology, Inc. Common stock US flag

NASDAQ Global Select

56.37

USD

+0.84

- -

4.97BMarket Cap

Profitability (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-34.34	-28.01	-18.45	-20.82
Return on Capital (%)	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	-15.02
EBITDA Margin (%)	-121.61	-18,445.55	-27,172.55	-10,064.44	-4,686.36
Operating Margin (%)	-121.7	-18,453.4	-27,180.88	-10,067.25	-4,722.13
Incremental Operating Margin (%)	- -	- -	- -	- -	- -
Pretax Margin (%)	-123.95	-18,556.54	-23,826.96	-7,729.5	-3,985.02
Profit Margin (%)	-123.95	-18,556.54	-23,826.96	-7,729.5	-3,985.02
Net Income to Common Margin (%)	-177.48	-22,925.65	-33,234.31	-7,729.5	-3,985.02
Effective Tax Rate (%)	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	30.16	19.06	28.31	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	15	16	- -	- -	7
ST Debt	3	9	- -	- -	1
LT Debt	12	7	- -	- -	6
Total Debt/EBITDA	-1.2	-0.45	-0.01	- -	-0.04
Net Debt/EBITDA	3.06	2.06	0.15	2.24	0.16
Total Debt/EBIT	-1.2	-0.45	-0.01	- -	-0.04
Net Debt/EBIT	3.06	2.06	0.15	2.24	0.15
EBITDA to Interest Expense	-27.93	-35,231	- -	- -	- -
EBITDA-CapEx/Interest Expense	-28.14	-35,245	- -	- -	- -
EBIT to Interest Expense	-27.95	-35,246	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -
Common Equity/Total Assets	-78.19	-55.05	-65.2	-28.88	-47.87
Long-Term Debt/Equity (%)	30.1	5.42	0.13	0.01	0.81
Long-Term Debt/Capital (%)	23.25	4.94	0.14	-0.02	-1.64
Long-Term Debt/Total Assets (%)	20.64	4.6	0.12	0.01	0.77
Total Debt/Equity (%)	37.59	12.74	0.25	0.03	0.93
Total Debt/Capital (%)	29.03	11.6	0.26	-0.11	-1.89
Total Debt/Total Assets (%)	25.78	10.79	0.23	0.03	0.89
Net Debt to Equity	-95.9	-58.03	-4.47	-35.05	-3.92
Net Debt/Capital (%)	2,573.33	-147.25	-4.86	54.14	7.29
EBITDA	-13	-35	-55	-115	-189
EBITDA-CapEx	-13	-35	-55	-115	-189
Operating Income (Loss)	-13	-35	-55	-115	-191

Liquidity (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	8.97	9.3	13.17	34.72	24.07
Current Ratio	9.78	9.54	13.62	35.3	24.63
Quick Ratio	8.97	9.32	13.17	34.72	24.09
CFO/Avg Current Liab	- -	-2.78	-3.08	-4.42	-5.07
Common Equity/Total Assets	-78.19	-55.05	-65.2	-28.88	-47.87
Long-Term Debt/Equity (%)	30.1	5.42	0.13	0.01	0.81
Long-Term Debt/Capital (%)	23.25	4.94	0.14	-0.02	-1.64
Long-Term Debt/Total Assets (%)	20.64	4.6	0.12	0.01	0.77
Total Debt/Equity (%)	37.59	12.74	0.25	0.03	0.93
Total Debt/Capital (%)	29.03	11.6	0.26	-0.11	-1.89
Total Debt/Total Assets (%)	25.78	10.79	0.23	0.03	0.89
CFO/Total Liabilities	-74.05	-132.05	-314.79	-367.47	-339.44
CFO/CapEx	-140.76	-2,128.86	- -	-336.38	-987.66
Altman's Z-Score	-0.55	-0.49	-0.75	50.47	-0.36

Working Capital (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	11.74
Days Sales Outstanding	- -	- -	- -	- -	31.08
Inventory Turnover	- -	- -	- -	- -	5.94
Days Inventory Outstanding	- -	- -	- -	- -	61.46
Accounts Payable Turnover	- -	- -	- -	- -	1.02
Accounts Payable Turnover Days	- -	- -	- -	- -	359.33
Cash Conversion Cycle	- -	- -	- -	- -	-266.79
Inventory to Cash Days	- -	- -	- -	- -	-30.38
Inventories	- -	- -	- -	- -	2
Raw Materials	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	2

Enterprise Value (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	1,792	- -
- Cash & Cash Equivalents	54	88	8	257	32
+ Preferred Equity and Hybrid Capital	83	203	308	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
+ Total Debt	15	16	- -	- -	7
Enterprise Value	44	75	121	1,051	-735
Total Capital	52	137	178	-218	-372
Total Debt/Capital (%)	29.03	11.6	0.26	-0.11	-1.89
Total Debt / EV	0.34	0.21	- -	- -	-0.01
EV/Sales	4.29	394.41	591.55	922.43	- -
EV/EBITDA	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	1,792	- -
Diluted Enterprise Value	44	131	300	1,536	-25
EV per Share	1.32	20.14	27.86	16.81	- -
TTM Sales	10	- -	- -	1	4
TTM EBITDA	-13	-35	-55	-115	-189
TTM Operating Income	-13	-35	-55	-115	-191
TTM Cash Flow to Firm	-13	-30	-46	-79	-132
TTM Free Cash Flow to Firm	-13	-30	-46	-78	-132

Multiples (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	-22.84	- -
EV/EBIT	- -	- -	- -	- -	- -
Enterprise Value	44	75	121	1,051	-735
Low Price	- -	- -	- -	25.77	14.8
EV/Sales	4.29	394.41	591.55	922.43	- -
EV/EBITDA	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-25.43	- -
Price/Earnings High	- -	- -	- -	-35.66	- -
Price/Earnings Low	- -	- -	- -	-18.29	- -
Price/Book Value	- -	- -	- -	-8.22	- -
Price/Book Value Average	- -	- -	- -	-10.27	- -
Price/Book Value High	- -	- -	- -	-14.4	- -
Price/Book Value Low	- -	- -	- -	-7.39	- -
Price/Tangible Book Value	- -	- -	- -	2.44	- -
Price/Tangible Book Value Average	- -	- -	- -	3.05	- -
Price/Tangible Book Value High	- -	- -	- -	4.28	- -
Price/Tangible Book Value Low	- -	- -	- -	2.2	- -
Price/Sales	- -	- -	- -	1,573.67	- -
Price/Sales Average	- -	- -	- -	1,965.71	- -
Price/Sales High	- -	- -	- -	2,756.11	- -
Price/Sales Low	- -	- -	- -	1,414	- -
Price/Cash Flow	- -	- -	- -	-22.77	- -
Price/Cash Flow Average	- -	- -	- -	-28.44	- -
Price/Cash Flow High	- -	- -	- -	-39.88	- -
Price/Cash Flow Low	- -	- -	- -	-20.46	- -
Price/Free Cash Flow Average	- -	- -	- -	-28.53	- -
Price/Free Cash Flow High	- -	- -	- -	-40	- -
Price/Free Cash Flow Low	- -	- -	- -	-20.52	- -
EV/Sales Average	4.29	684.14	1,471	1,740.22	- -
EV/Sales High	4.29	684.14	1,471	2,530.62	- -
EV/Sales Low	4.29	684.14	1,471	1,188.51	- -
EV/EBITDA Average	-3.52	-3.71	-5.41	-17.29	0.13
EV/EBITDA High	-3.52	-3.71	-5.41	-25.14	0.13
EV/EBITDA Low	-3.52	-3.71	-5.41	-11.81	0.13
EV/EBIT Average	-3.52	-3.71	-5.41	-17.29	0.13
EV/EBIT High	-3.52	-3.71	-5.41	-25.14	0.13
EV/EBIT Low	-3.52	-3.71	-5.41	-11.81	0.13
Last Price	- -	- -	- -	28.68	41.52
High Price	- -	- -	- -	50.23	46.01
Enterprise Value Average	44	131	300	1,982	-25
Enterprise Value High	44	131	300	2,882	-25
Enterprise Value Low	44	131	300	1,354	-25

Profitability (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-34.34	-28.01	-18.45	-20.82
Return on Capital (%)	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	-15.02
EBITDA Margin (%)	-121.61	-18,445.55	-27,172.55	-10,064.44	-4,686.36
Operating Margin (%)	-121.7	-18,453.4	-27,180.88	-10,067.25	-4,722.13
Incremental Operating Margin (%)	- -	- -	- -	- -	- -
Pretax Margin (%)	-123.95	-18,556.54	-23,826.96	-7,729.5	-3,985.02
Profit Margin (%)	-123.95	-18,556.54	-23,826.96	-7,729.5	-3,985.02
Net Income to Common Margin (%)	-177.48	-22,925.65	-33,234.31	-7,729.5	-3,985.02
Effective Tax Rate (%)	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	30.16	19.06	28.31	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	15	16	- -	- -	7
ST Debt	3	9	- -	- -	1
LT Debt	12	7	- -	- -	6
Total Debt/EBITDA	-1.2	-0.45	-0.01	- -	-0.04
Net Debt/EBITDA	3.06	2.06	0.15	2.24	0.16
Total Debt/EBIT	-1.2	-0.45	-0.01	- -	-0.04
Net Debt/EBIT	3.06	2.06	0.15	2.24	0.15
EBITDA to Interest Expense	-27.93	-35,231	- -	- -	- -
EBITDA-CapEx/Interest Expense	-28.14	-35,245	- -	- -	- -
EBIT to Interest Expense	-27.95	-35,246	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -
Common Equity/Total Assets	-78.19	-55.05	-65.2	-28.88	-47.87
Long-Term Debt/Equity (%)	30.1	5.42	0.13	0.01	0.81
Long-Term Debt/Capital (%)	23.25	4.94	0.14	-0.02	-1.64
Long-Term Debt/Total Assets (%)	20.64	4.6	0.12	0.01	0.77
Total Debt/Equity (%)	37.59	12.74	0.25	0.03	0.93
Total Debt/Capital (%)	29.03	11.6	0.26	-0.11	-1.89
Total Debt/Total Assets (%)	25.78	10.79	0.23	0.03	0.89
Net Debt to Equity	-95.9	-58.03	-4.47	-35.05	-3.92
Net Debt/Capital (%)	2,573.33	-147.25	-4.86	54.14	7.29
EBITDA	-13	-35	-55	-115	-189
EBITDA-CapEx	-13	-35	-55	-115	-189
Operating Income (Loss)	-13	-35	-55	-115	-191

Liquidity (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	8.97	9.3	13.17	34.72	24.07
Current Ratio	9.78	9.54	13.62	35.3	24.63
Quick Ratio	8.97	9.32	13.17	34.72	24.09
CFO/Avg Current Liab	- -	-2.78	-3.08	-4.42	-5.07
Common Equity/Total Assets	-78.19	-55.05	-65.2	-28.88	-47.87
Long-Term Debt/Equity (%)	30.1	5.42	0.13	0.01	0.81
Long-Term Debt/Capital (%)	23.25	4.94	0.14	-0.02	-1.64
Long-Term Debt/Total Assets (%)	20.64	4.6	0.12	0.01	0.77
Total Debt/Equity (%)	37.59	12.74	0.25	0.03	0.93
Total Debt/Capital (%)	29.03	11.6	0.26	-0.11	-1.89
Total Debt/Total Assets (%)	25.78	10.79	0.23	0.03	0.89
CFO/Total Liabilities	-74.05	-132.05	-314.79	-367.47	-339.44
CFO/CapEx	-140.76	-2,128.86	- -	-336.38	-987.66
Altman's Z-Score	-0.55	-0.49	-0.75	50.47	-0.36

Working Capital (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	11.74
Days Sales Outstanding	- -	- -	- -	- -	31.08
Inventory Turnover	- -	- -	- -	- -	5.94
Days Inventory Outstanding	- -	- -	- -	- -	61.46
Accounts Payable Turnover	- -	- -	- -	- -	1.02
Accounts Payable Turnover Days	- -	- -	- -	- -	359.33
Cash Conversion Cycle	- -	- -	- -	- -	-266.79
Inventory to Cash Days	- -	- -	- -	- -	-30.38
Inventories	- -	- -	- -	- -	2
Raw Materials	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	2

Enterprise Value (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	1,792	- -
- Cash & Cash Equivalents	54	88	8	257	32
+ Preferred Equity and Hybrid Capital	83	203	308	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
+ Total Debt	15	16	- -	- -	7
Enterprise Value	44	75	121	1,051	-735
Total Capital	52	137	178	-218	-372
Total Debt/Capital (%)	29.03	11.6	0.26	-0.11	-1.89
Total Debt / EV	0.34	0.21	- -	- -	-0.01
EV/Sales	4.29	394.41	591.55	922.43	- -
EV/EBITDA	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	1,792	- -
Diluted Enterprise Value	44	131	300	1,536	-25
EV per Share	1.32	20.14	27.86	16.81	- -
TTM Sales	10	- -	- -	1	4
TTM EBITDA	-13	-35	-55	-115	-189
TTM Operating Income	-13	-35	-55	-115	-191
TTM Cash Flow to Firm	-13	-30	-46	-79	-132
TTM Free Cash Flow to Firm	-13	-30	-46	-78	-132

Multiples (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	-22.84	- -
EV/EBIT	- -	- -	- -	- -	- -
Enterprise Value	44	75	121	1,051	-735
Low Price	- -	- -	- -	25.77	14.8
EV/Sales	4.29	394.41	591.55	922.43	- -
EV/EBITDA	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-25.43	- -
Price/Earnings High	- -	- -	- -	-35.66	- -
Price/Earnings Low	- -	- -	- -	-18.29	- -
Price/Book Value	- -	- -	- -	-8.22	- -
Price/Book Value Average	- -	- -	- -	-10.27	- -
Price/Book Value High	- -	- -	- -	-14.4	- -
Price/Book Value Low	- -	- -	- -	-7.39	- -
Price/Tangible Book Value	- -	- -	- -	2.44	- -
Price/Tangible Book Value Average	- -	- -	- -	3.05	- -
Price/Tangible Book Value High	- -	- -	- -	4.28	- -
Price/Tangible Book Value Low	- -	- -	- -	2.2	- -
Price/Sales	- -	- -	- -	1,573.67	- -
Price/Sales Average	- -	- -	- -	1,965.71	- -
Price/Sales High	- -	- -	- -	2,756.11	- -
Price/Sales Low	- -	- -	- -	1,414	- -
Price/Cash Flow	- -	- -	- -	-22.77	- -
Price/Cash Flow Average	- -	- -	- -	-28.44	- -
Price/Cash Flow High	- -	- -	- -	-39.88	- -
Price/Cash Flow Low	- -	- -	- -	-20.46	- -
Price/Free Cash Flow Average	- -	- -	- -	-28.53	- -
Price/Free Cash Flow High	- -	- -	- -	-40	- -
Price/Free Cash Flow Low	- -	- -	- -	-20.52	- -
EV/Sales Average	4.29	684.14	1,471	1,740.22	- -
EV/Sales High	4.29	684.14	1,471	2,530.62	- -
EV/Sales Low	4.29	684.14	1,471	1,188.51	- -
EV/EBITDA Average	-3.52	-3.71	-5.41	-17.29	0.13
EV/EBITDA High	-3.52	-3.71	-5.41	-25.14	0.13
EV/EBITDA Low	-3.52	-3.71	-5.41	-11.81	0.13
EV/EBIT Average	-3.52	-3.71	-5.41	-17.29	0.13
EV/EBIT High	-3.52	-3.71	-5.41	-25.14	0.13
EV/EBIT Low	-3.52	-3.71	-5.41	-11.81	0.13
Last Price	- -	- -	- -	28.68	41.52
High Price	- -	- -	- -	50.23	46.01
Enterprise Value Average	44	131	300	1,982	-25
Enterprise Value High	44	131	300	2,882	-25
Enterprise Value Low	44	131	300	1,354	-25

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	63	63	63	76	81
Diluted Weighted Avg Shares	34	4	4	62	- -
Basic Weighted Avg Shares	34	4	4	62	- -
Revenue per Share	0.31	0.05	0.05	0.02	- -
EBITDA per Share	-0.37	-9.42	-12.8	-1.83	- -
Operating Income per Share	-0.37	-9.42	-12.8	-1.83	- -
Basic EPS, GAAP	-0.55	-11.71	-15.65	-1.41	- -
Basic EPS from Cont Ops	-0.38	-9.47	-11.22	-1.41	- -
Diluted EPS, GAAP	-0.55	-11.71	-15.65	-1.41	- -
Diluted EPS from Cont Ops	-0.38	-9.47	-11.22	-1.41	- -
Dividend per Share	- -	- -	- -	- -	- -
Cash Flow per Share	-0.41	-7.97	-10.55	-1.26	- -
Free Cash Flow per Basic Share	-0.41	-7.97	-10.55	-1.26	- -
Cash & Equivalents per Share	1.59	38.35	43.33	11.87	- -
Book Value per Share	-1.36	-21.74	-30	-3.49	- -
Tangible Book Value per Share	-1.26	-20.77	-28.42	11.73	- -

CG Oncology, Inc. Common stock

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)